Do climate risk disclosures matter to financial analysts?
Journal of Business Finance & Accounting · 2024-07 · 51 (7-8) · 2153-2180
DOI: 10.1111/jbfa.12778 ↗At a glance
Journal article in Journal of Business Finance & Accounting, published online on 2023-12-26. Written by Walid Ben‐Amar and 2 co-authors. Cited 57 times so far (Crossref); 51 references.
Abstract (original language)
This paper examines whether and when corporate disclosures about a firm's exposure to climate risks matter to financial analysts. More specifically, we investigate the association between climate risk disclosure (CRD) and two properties of financial analysts’ earnings forecasts (accuracy and dispersion). We predict that climate risk financial materiality at the industry level moderates this association. Using a sample of 2184 US nonfinancial firm‐year observations over the period 2010–2016, we show that CRD is associated with higher forecast precision and lower dispersion only when climate risks are perceived by investors as being financially material at the industry level. We also find that while corporate disclosures about transition risks are not associated with financial analyst forecast properties, 10‐K disclosures about climate‐related material physical risks reduce analyst forecast error and dispersion.
Cite
APA
Ben‐Amar, W., Herrera, D. C., & Martinez, I. (2024). Do climate risk disclosures matter to financial analysts?. Journal of Business Finance & Accounting, 51(7-8), 2153-2180. https://doi.org/10.1111/jbfa.12778
Vancouver
Ben‐Amar W, Herrera DC, Martinez I. Do climate risk disclosures matter to financial analysts?. Journal of Business Finance & Accounting. 2024;51(7-8):2153-2180. doi:10.1111/jbfa.12778
BibTeX
@article{BenAmar2024,
author = {Ben‐Amar, Walid and Herrera, Diana Castro and Martinez, Isabelle},
title = {Do climate risk disclosures matter to financial analysts?},
journal = {Journal of Business Finance & Accounting},
year = {2024},
volume = {51},
number = {7-8},
pages = {2153--2180},
doi = {10.1111/jbfa.12778}
}
EUVIMED